Exact Mass: 460.28288339999995
Exact Mass Matches: 460.28288339999995
Found 500 metabolites which its exact mass value is equals to given mass value 460.28288339999995
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sophoranone
A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7 and 4 and prenyl groups at positions 3 and 5 respectively.
ST 27:4;O6
Same as: D09796
4,4-Diapolycopene-4,4-dioate
Lucidenic acid N
Lucidenic acid N is found in mushrooms. Lucidenic acid N is a constituent of Ganoderma lucidum (reishi).
2,3-Secoporrigenin
(6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is found in onion-family vegetables. (6beta,25S)-2,3-Secospirostan-3,6-olid-2-oic acid is a constituent of Allium porrum (leek)
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate
C23H41O7P (460.25897660000004)
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:3(5Z,8Z,11Z)/0:0)
C23H41O7P (460.25897660000004)
LysoPA(20:3(5Z,8Z,11Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(5Z,8Z,11Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(20:3(8Z,11Z,14Z)/0:0)
C23H41O7P (460.25897660000004)
LysoPA(20:3(8Z,11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Fluocortolone Pivalate
Menatetrenone Epoxide
Milciclib
C25H32N8O (460.26989419999995)
Petrosaspongiolide m
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)
DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))
DG(2:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0)
DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)
DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))
DG(2:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0)
DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))
DG(2:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)
DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))
DG(2:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0)
DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)
DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))
DG(2:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0)
DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Lucidenic acid N
Lucidenic acid N is a tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. It has a role as a metabolite, an EC 3.1.1.8 (cholinesterase) inhibitor and an antineoplastic agent. It is a tetracyclic triterpenoid, a cyclic terpene ketone, a dioxo monocarboxylic acid and a secondary alcohol. Lucidenic acid N is a natural product found in Ganoderma lucidum and Bos taurus with data available. A tetracyclic triterpenoid that is 25,26,27-trinorlanost-8-en-24-oic acid substituted by hydroxy groups at positions 3 and 7 and oxo groups at positions 11 and 15 respectively (the 3beta,5alpha,7beta stereoisomer). Isolated from the fruiting bodies of Ganoderma lucidum, it exhibits cytotoxicity against tumour cells. Constituent of Ganoderma lucidum (reishi). Lucidenic acid N is found in mushrooms.
2,3-Dihydro-11,11-bis(3-methyl-2-butenyl)-5,6-dihydroxy-2,2,3,8-tetramethylanthra[2,3-b]furan-4(11H)-one
Rudbeckiolide
Sanggenofuran A
12beta,20-Dihydroxy-16beta-Acetoxy-17-scalaren-19,20-olide
Kazinol H
Munchiwarin
Sophoradin
Milciclib
C25H32N8O (460.26989419999995)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(2S)-3,4-dihydro-7-hydroxy-2,2-dimethyl-8,8-bis(3-methylbut-2-enyl)-[2,6-bi-2H-1-benzopyran]-4(3H)-one|tokinochromane B
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitate
6-[1-hydroxy-3-(4-hydroxyphenyl)allylidene]-2,2,4-tris(3-methylbut-2-enyl)cyclohex-4-ene-1,3-dione|munchiwarin
2-Propyl-8-hydroxymethyl-12,14-dimethyl-15-benzyl-1-oxa-7,14-diazacyclohexadecane-6,13,16-trione
C26H40N2O5 (460.29370700000004)
namogenin C|spirosta-5,25(27)-dien-1beta,3beta,14alpha,17alpha-tetrol
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-7beta,10alphaH-eremophil-11-ene-8-one
1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
3alpha,9beta,13alpha-trihydroxy-11(12),15(17)-trinervitadiene propionate diacetate
(2S)-2-[3,4-dihydro-2,2-dimethyl-8-(3-methylbut-2-enyl)-2H-1-benzopyran-6-yl]-2,3,9,10-tetrahydro-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one|tokinochromane A
spirosta-5,25(27)-diene-1beta,2alpha,3beta,12beta-tetrol
6-Angeloyl,7-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid
7beta-hydroxy-11-oxo-3,4-seco-25,26,27-trinorlanosta-4(28),8-dien-3,24-dioic acid|fornicatin B
12-amino-9-sec-butyl-6-(1-hydroxy-1-methyl-propyl)-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione|Zizyphine E|Zizyphine-E
3alpha-(4-pent-2E-enoyloxy-pent-2E-enoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<4-pent-2E-enoyloxy-pent-2E-enoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
Eicosapentaenoyl Serotonin
Ser Arg Ala Lys
Ser Ile Asn Lys
Ser Gln Val Lys
3β,7β,15β-Trihydroxy-11-oxo-lanosta-8-en-24→20 lactone
7,15-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8-en-24-oic acid
Ala Asp Lys Lys
Ala Lys Asp Lys
Ala Lys Lys Asp
Ala Lys Arg Ser
Ala Lys Ser Arg
Ala Arg Lys Ser
Ala Arg Ser Lys
Ala Ser Lys Arg
Ala Ser Arg Lys
Cys Ile Ile Ile
C21H40N4O5S (460.27192700000006)
Cys Ile Ile Leu
C21H40N4O5S (460.27192700000006)
Cys Ile Leu Ile
C21H40N4O5S (460.27192700000006)
Cys Ile Leu Leu
C21H40N4O5S (460.27192700000006)
Cys Leu Ile Ile
C21H40N4O5S (460.27192700000006)
Cys Leu Ile Leu
C21H40N4O5S (460.27192700000006)
Cys Leu Leu Ile
C21H40N4O5S (460.27192700000006)
Cys Leu Leu Leu
C21H40N4O5S (460.27192700000006)
Asp Ala Lys Lys
Asp Lys Ala Lys
Asp Lys Lys Ala
Glu Gly Lys Lys
Glu Lys Gly Lys
Glu Lys Lys Gly
Phe Pro Val Val
Phe Val Pro Val
Phe Val Val Pro
Gly Glu Lys Lys
Gly Lys Glu Lys
Gly Lys Lys Glu
Gly Lys Arg Thr
Gly Lys Thr Arg
Gly Arg Lys Thr
Gly Arg Thr Lys
Gly Thr Lys Arg
Gly Thr Arg Lys
Ile Cys Ile Ile
C21H40N4O5S (460.27192700000006)
Ile Cys Ile Leu
C21H40N4O5S (460.27192700000006)
Ile Cys Leu Ile
C21H40N4O5S (460.27192700000006)
Ile Cys Leu Leu
C21H40N4O5S (460.27192700000006)
Ile Ile Cys Ile
C21H40N4O5S (460.27192700000006)
Ile Ile Cys Leu
C21H40N4O5S (460.27192700000006)
Ile Ile Ile Cys
C21H40N4O5S (460.27192700000006)
Ile Ile Leu Cys
C21H40N4O5S (460.27192700000006)
Ile Lys Asn Ser
Ile Lys Ser Asn
Ile Leu Cys Ile
C21H40N4O5S (460.27192700000006)
Ile Leu Cys Leu
C21H40N4O5S (460.27192700000006)
Ile Leu Ile Cys
C21H40N4O5S (460.27192700000006)
Ile Leu Leu Cys
C21H40N4O5S (460.27192700000006)
Ile Met Val Val
C21H40N4O5S (460.27192700000006)
Ile Asn Lys Ser
Ile Asn Ser Lys
Ile Ser Lys Asn
Ile Ser Asn Lys
Ile Val Met Val
C21H40N4O5S (460.27192700000006)
Ile Val Val Met
C21H40N4O5S (460.27192700000006)
Lys Ala Asp Lys
Lys Ala Lys Asp
Lys Ala Arg Ser
Lys Ala Ser Arg
Lys Asp Ala Lys
Lys Asp Lys Ala
Lys Glu Gly Lys
Lys Glu Lys Gly
Lys Gly Glu Lys
Lys Gly Lys Glu
Lys Gly Arg Thr
Lys Gly Thr Arg
Lys Ile Asn Ser
Lys Ile Ser Asn
Lys Lys Ala Asp
Lys Lys Asp Ala
Lys Lys Glu Gly
Lys Lys Gly Glu
Lys Lys Ser Val
Lys Lys Val Ser
Lys Leu Asn Ser
Lys Leu Ser Asn
Lys Asn Ile Ser
Lys Asn Leu Ser
Lys Asn Ser Ile
Lys Asn Ser Leu
Lys Asn Thr Val
Lys Asn Val Thr
Lys Gln Ser Val
Lys Gln Val Ser
Lys Arg Ala Ser
Lys Arg Gly Thr
Lys Arg Ser Ala
Lys Arg Thr Gly
Lys Ser Ala Arg
Lys Ser Ile Asn
Lys Ser Lys Val
Lys Ser Leu Asn
Lys Ser Asn Ile
Lys Ser Asn Leu
Lys Ser Gln Val
Lys Ser Arg Ala
Lys Ser Val Lys
Lys Ser Val Gln
Lys Thr Gly Arg
Lys Thr Asn Val
Lys Thr Arg Gly
Lys Thr Val Asn
Lys Val Lys Ser
Lys Val Asn Thr
Lys Val Gln Ser
Lys Val Ser Lys
Lys Val Ser Gln
Lys Val Thr Asn
Leu Cys Ile Ile
C21H40N4O5S (460.27192700000006)
Leu Cys Ile Leu
C21H40N4O5S (460.27192700000006)
Leu Cys Leu Ile
C21H40N4O5S (460.27192700000006)
Leu Cys Leu Leu
C21H40N4O5S (460.27192700000006)
Leu Ile Cys Ile
C21H40N4O5S (460.27192700000006)
Leu Ile Cys Leu
C21H40N4O5S (460.27192700000006)
Leu Ile Ile Cys
C21H40N4O5S (460.27192700000006)
Leu Ile Leu Cys
C21H40N4O5S (460.27192700000006)
Leu Lys Asn Ser
Leu Lys Ser Asn
Leu Leu Cys Ile
C21H40N4O5S (460.27192700000006)
Leu Leu Cys Leu
C21H40N4O5S (460.27192700000006)
Leu Leu Ile Cys
C21H40N4O5S (460.27192700000006)
Leu Leu Leu Cys
C21H40N4O5S (460.27192700000006)
Leu Met Val Val
C21H40N4O5S (460.27192700000006)
Leu Asn Lys Ser
Leu Asn Ser Lys
Leu Ser Lys Asn
Leu Ser Asn Lys
Leu Val Met Val
C21H40N4O5S (460.27192700000006)
Leu Val Val Met
C21H40N4O5S (460.27192700000006)
Met Ile Val Val
C21H40N4O5S (460.27192700000006)
Met Leu Val Val
C21H40N4O5S (460.27192700000006)
Met Val Ile Val
C21H40N4O5S (460.27192700000006)
Met Val Leu Val
C21H40N4O5S (460.27192700000006)
Met Val Val Ile
C21H40N4O5S (460.27192700000006)
Met Val Val Leu
C21H40N4O5S (460.27192700000006)
Asn Ile Lys Ser
Asn Ile Ser Lys
Asn Lys Ile Ser
Asn Lys Leu Ser
Asn Lys Ser Ile
Asn Lys Ser Leu
Asn Lys Thr Val
Asn Lys Val Thr
Asn Leu Lys Ser
Asn Leu Ser Lys
Asn Ser Ile Lys
Asn Ser Lys Ile
Asn Ser Lys Leu
Asn Ser Leu Lys
Asn Thr Lys Val
Asn Thr Val Lys
Asn Val Lys Thr
Asn Val Thr Lys
Pro Phe Val Val
Pro Val Phe Val
Pro Val Val Phe
Gln Lys Ser Val
Gln Lys Val Ser
Gln Ser Lys Val
Gln Ser Val Lys
Gln Val Lys Ser
Gln Val Ser Lys
Arg Ala Lys Ser
Arg Ala Ser Lys
Arg Gly Lys Thr
Arg Gly Thr Lys
Arg Lys Ala Ser
Arg Lys Gly Thr
Arg Lys Ser Ala
Arg Lys Thr Gly
Arg Ser Ala Lys
Arg Ser Lys Ala
Arg Thr Gly Lys
Arg Thr Lys Gly
Ser Ala Lys Arg
Ser Ala Arg Lys
Ser Ile Lys Asn
Ser Lys Ala Arg
Ser Lys Ile Asn
Ser Lys Lys Val
Ser Lys Leu Asn
Ser Lys Asn Ile
Ser Lys Asn Leu
Ser Lys Gln Val
Ser Lys Arg Ala
Ser Lys Val Lys
Ser Lys Val Gln
Ser Leu Lys Asn
Ser Leu Asn Lys
Ser Asn Ile Lys
Ser Asn Lys Ile
Ser Asn Lys Leu
Ser Asn Leu Lys
Ser Gln Lys Val
Ser Arg Lys Ala
Ser Val Lys Lys
Ser Val Lys Gln
Ser Val Gln Lys
Thr Gly Lys Arg
Thr Gly Arg Lys
Thr Lys Gly Arg
Thr Lys Asn Val
Thr Lys Arg Gly
Thr Lys Val Asn
Thr Asn Lys Val
Thr Asn Val Lys
Thr Arg Gly Lys
Thr Arg Lys Gly
Thr Val Lys Asn
Thr Val Asn Lys
Val Phe Pro Val
Val Phe Val Pro
Val Ile Met Val
C21H40N4O5S (460.27192700000006)
Val Ile Val Met
C21H40N4O5S (460.27192700000006)
Val Lys Lys Ser
Val Lys Asn Thr
Val Lys Gln Ser
Val Lys Ser Lys
Val Lys Ser Gln
Val Lys Thr Asn
Val Leu Met Val
C21H40N4O5S (460.27192700000006)
Val Leu Val Met
C21H40N4O5S (460.27192700000006)
Val Met Ile Val
C21H40N4O5S (460.27192700000006)
Val Met Leu Val
C21H40N4O5S (460.27192700000006)
Val Met Val Ile
C21H40N4O5S (460.27192700000006)
Val Met Val Leu
C21H40N4O5S (460.27192700000006)
Val Asn Lys Thr
Val Asn Thr Lys
Val Pro Phe Val
Val Pro Val Phe
Val Gln Lys Ser
Val Gln Ser Lys
Val Ser Lys Lys
Val Ser Lys Gln
Val Ser Gln Lys
Val Thr Lys Asn
Val Thr Asn Lys
Val Val Phe Pro
Val Val Ile Met
C21H40N4O5S (460.27192700000006)
Val Val Leu Met
C21H40N4O5S (460.27192700000006)
Val Val Met Ile
C21H40N4O5S (460.27192700000006)
Val Val Met Leu
C21H40N4O5S (460.27192700000006)
Val Val Pro Phe
(6R)-vitamin D2 6,19-sulfur dioxide adduct / (6R)-ergocalciferol 6,19-sulfur dioxide adduct
(6S)-vitamin D2 6,19-sulfur dioxide adduct / (6S)-ergocalciferol 6,19-sulfur dioxide adduct
PA(20:3(8Z,11Z,14Z)/0:0)
C23H41O7P (460.25897660000004)
2,3-Secoporrigenin
(6R)-vitamin D2 6,19-sulfur dioxide adduct
(6S)-vitamin D2 6,19-sulfur dioxide adduct
Omega-hydroxymenaquinone-4
A prenylnaphthoquinone obtained by hydroxylation of one of the terminal methyl groups of menaquinone-4.
6b-Hydroxymethandienone
C26H44O3Si2 (460.28288339999995)
6b-Hydroxymethandienone is a metabolite of the androgen metandienone metabolite, excreted in the urine. Metandienone has been used in horse doping and by weightlifters and body builders. It is of note to consider that the use of anabolic steroids for an extended period of time reduces the excretion of endogenous metabolites, making the detection of doping a little more difficult. (PMID: 16040239, 757586, 9001954, 2745643, 12375280, 8539789, 1400752, 757586, 17610244) [HMDB]
Entereg
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist D005765 - Gastrointestinal Agents Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].
1,1-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-(isopropylamino)-2-propanol]
C26H40N2O5 (460.29370700000004)
Acetylphenylalanyl-prolyl-boroarginine
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
Fluocortolone Pivalate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D000893 - Anti-Inflammatory Agents
H-Lys-Trp-Lys-OH
H-Lys-Trp-Lys-OH is a small molecule peptide which displays antibacterial and antiviral activities extracted from patent CN 104072579 A, Compound AMP12.
[3-carboxy-2-[(E)-7-[(5Z)-5-[(E)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxypropyl]-trimethylazanium
C27H42NO5+ (460.30628220000006)
1-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[2-(dipropylamino)ethyl]-4-piperidinecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
(6S,7R,8aR)-N-[6-(dimethylamino)hexyl]-6-[3-(2-hydroxyethoxy)phenyl]-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-7-carboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
1-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-cyclohexyl-3-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
C25H40N4O4 (460.30494000000004)
1-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
1-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C25H40N4O4 (460.30494000000004)
(2-hydroxy-3-phosphonooxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
C23H41O7P (460.25897660000004)
[(4E,8E,12E)-2-acetamido-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H41N2O6P (460.27020960000004)
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H41N2O6P (460.27020960000004)
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedioic acid
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate
C23H41O7P (460.25897660000004)
(7E)-(3S,6R)-6,19-epithio-9,10-seco-5(10),7,22-ergostatrien-3-ol S,S-dioxide
4,4-diapolycopenedioic acid
An apo carotenoid triterpenoid that is 4,4-diapolycopene in which two of the terminal methyl groups have been oxidised to carboxy groups.
2,3-epoxymenatetrenone
A member of the class of tetralins obtained by formal epoxidation across the 2,3-double bond of menatetrenone.
TG(24:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(4s)-4-[2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-1-benzopyran-6-yl]-12,12-dimethyl-3,11-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1,7,9-trien-6-one
7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-6,8-bis(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(1r,2r,4r,5s,8r,13s,14s,17s,18r,20r)-5,9,9,13-tetramethyl-22-oxo-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-2-yl acetate
(3s,4ar,6ar,8s,10r,10ar,10bs)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate
2-[2-(4-methoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(1e)-2-[(4r,5s,7s,8s)-8-(hydroxymethyl)-7,8-dimethoxy-2,5-dimethyl-5-(4-methylpent-3-en-1-yl)-4h,6h,7h-cyclohepta[b]furan-4-yl]ethenyl 3-methylbut-2-enoate
(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13'r,16'r,18's,19'r)-16',19'-dihydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-10',15'-dione
(1s,2s,8s,11r,12r,15s)-1,2,8,15-tetramethyl-5,18-bis(propan-2-ylidene)pentacyclo[10.8.0.0²,¹¹.0³,⁹.0¹⁴,²⁰]icosa-3(9),14(20)-diene-6,10,13,17-tetrone
(4s)-3,8,9-trihydroxy-6-methyl-4,5,7-tris(3-methylbut-2-en-1-yl)-4h-anthracen-1-one
(1s,2s,8r,11r,12r,15s)-1,2,8,15-tetramethyl-5,18-bis(propan-2-ylidene)pentacyclo[10.8.0.0²,¹¹.0³,⁹.0¹⁴,²⁰]icosa-3(9),14(20)-diene-6,10,13,17-tetrone
(2s,3as,5s)-3a-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(2-hydroxypropan-2-yl)-5-methyl-7-[(2r)-2-methylbutanoyl]-2,3-dihydro-1-benzofuran-4,6-dione
3-[(15-hydroxyhexadecyl)oxy]-5-methyl-1h,8h,8ah-3λ⁵-furo[3,4-e][1,3,2]dioxaphosphepine-3,6-dione
C23H41O7P (460.25897660000004)